V. Hofman, Mise en place d???indicateurs de suivi au sein d???une tumoroth??que et/ou d???un centre de ressources biologiques??: pourquoi et comment???, Annales de Pathologie, vol.32, issue.2, pp.91-101, 2012.
DOI : 10.1016/j.annpat.2012.02.002

T. Edwards, Biobanks containing clinical specimens: Defining characteristics, policies, and practices, Clinical Biochemistry, vol.47, issue.4-5, pp.4-5, 2014.
DOI : 10.1016/j.clinbiochem.2013.11.023

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959281

D. Deplanque, Collections of Human Biological Samples for Scientific Purposes. Why do Current Regulation Need to be Clarified and How?, Th??rapie, vol.64, issue.4, pp.215-239, 2009.
DOI : 10.2515/therapie/2009046

3. Le, R. Les, and . Biologiques, Available from: http://www.3cr- ressourcesbiologiques.com/. 10, BIOBANQUES, 2015.

E. C. Keeley, J. A. Boura, and C. L. Grines, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, The Lancet, vol.361, issue.9351, pp.361-374, 2003.
DOI : 10.1016/S0140-6736(03)12113-7

H. R. Andersen, A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, New England Journal of Medicine, issue.8, pp.349-733, 2003.

J. D. Watson and F. H. Crick, Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid, Nature, issue.4356, pp.171-737, 1953.

F. Cambien, Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction, Nature, vol.359, issue.6396, pp.359-641, 1992.
DOI : 10.1038/359641a0

J. Zhou, An Association Study between Genetic Polymorphism in the Interleukin-6 Receptor Gene and Coronary Heart Disease, BioMed Research International, vol.315, issue.7109, 2005.
DOI : 10.1007/s11033-012-2143-5

A. Vignal, A review on SNP and other types of molecular markers and their use in animal genetics, Genetics Selection Evolution, vol.34, issue.3, pp.275-305, 2002.
DOI : 10.1186/1297-9686-34-3-275

URL : https://hal.archives-ouvertes.fr/hal-00894413

F. S. Collins, Construction of a general human chromosome jumping library, with application to cystic fibrosis, Science, vol.235, issue.4792, pp.235-1046, 1987.
DOI : 10.1126/science.2950591

S. T. Warren, The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites, Science, vol.237, issue.4813, pp.237-420, 1987.
DOI : 10.1126/science.3603029

E. M. Ostertag, H. H. Kazazian, and J. , Biology of Mammalian L1 Retrotransposons, Annual Review of Genetics, vol.35, issue.1, pp.501-539, 2001.
DOI : 10.1146/annurev.genet.35.102401.091032

K. A. Nelson and J. S. Witte, Androgen Receptor CAG Repeats and Prostate Cancer, American Journal of Epidemiology, vol.155, issue.10, pp.883-90, 2002.
DOI : 10.1093/aje/155.10.883

URL : https://academic.oup.com/aje/article-pdf/155/10/883/9736432/883.pdf

M. Alhenc-gelas, A. M. Delahousse, and B. , La recherche des facteurs biologiques de risque établis de maladie thrombo-embolique veineuse : état des connaissances et conséquences pour la pratique en biologie clinique, pp.12-39, 2009.
DOI : 10.1016/j.jmv.2008.12.102

S. Eyre, High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis, Nature Genetics, vol.44, issue.12, pp.1336-1376, 2012.
DOI : 10.1371/journal.pgen.1002197

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605761

L. C. Tsoi, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nature Genetics, vol.177, issue.12, pp.44-1341, 2012.
DOI : 10.1038/ng1333

J. Z. Liu, Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis, Nature Genetics, vol.44, issue.10, pp.44-1137, 2012.
DOI : 10.1002/gepi.20579

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459817

A. Julia, A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis, Human Molecular Genetics, vol.23, issue.25, pp.23-6927, 2014.
DOI : 10.1093/hmg/ddu398

R. K. Saiki, Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science, vol.230, issue.4732, pp.230-1350, 1985.
DOI : 10.1126/science.2999980

C. A. Heid, Real time quantitative PCR., Genome Research, vol.6, issue.10, pp.986-94, 1996.
DOI : 10.1101/gr.6.10.986

N. J. Gibson, The use of real-time PCR methods in DNA sequence variation analysis, Clinica Chimica Acta, vol.363, issue.1-2, pp.32-47, 2006.
DOI : 10.1016/j.cccn.2005.06.022

J. T. Lu, P. M. Campeau, and B. H. Lee, Genotype???Phenotype Correlation ??? Promiscuity in the Era of Next-Generation Sequencing, New England Journal of Medicine, vol.371, issue.7, pp.371-593, 2014.
DOI : 10.1056/NEJMp1400788

M. L. Metzker, Sequencing technologies ??? the next generation, Nature Reviews Genetics, vol.37, issue.1, pp.31-46, 2010.
DOI : 10.1016/j.tig.2007.12.006

F. Eurofins-scientific, Available from: http://www.eurofins.fr/frfr/analyses/produits-alimentaires/ogm-et-genotypage .aspx. 35. Doutremepuich, C., [Legal implication of DNA profiling], Bull Acad Natl Med, vol.196, issue.1130, pp.1117-1146, 2012.

S. Kim and A. Misra, SNP Genotyping: Technologies and Biomedical Applications, Annual Review of Biomedical Engineering, vol.9, issue.1, pp.289-320, 2007.
DOI : 10.1146/annurev.bioeng.9.060906.152037

M. C. Prosperi, Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?, BMC Medical Informatics and Decision Making, vol.50, issue.11, 2014.
DOI : 10.18637/jss.v050.i11

L. Balabanski, Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects, Molecular and Clinical Oncology, vol.2, issue.3, pp.435-439, 2014.
DOI : 10.3892/mco.2014.251

A. R. Thierry, Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nature Medicine, vol.2, issue.4, pp.430-435, 2014.
DOI : 10.1038/ncponc0252

L. Su, Dynamic Changes in Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and its Gene Polymorphisms are Associated with Sepsis Prognosis, Inflammation, vol.10, issue.6, pp.35-1833, 2012.
DOI : 10.1038/nrg2579

C. Vecoli, Endothelial Nitric Oxide Synthase Gene Polymorphisms in Cardiovascular Disease, Vitam Horm, issue.96, pp.387-406, 2014.
DOI : 10.1016/B978-0-12-800254-4.00015-5

T. Simon, Genetic Determinants of Response to Clopidogrel and Cardiovascular Events, New England Journal of Medicine, vol.360, issue.4, pp.363-75, 2009.
DOI : 10.1056/NEJMoa0808227

J. L. Mega, Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI, JAMA, vol.304, issue.16, pp.304-1821, 2010.
DOI : 10.1001/jama.2010.1543

J. L. Mega, Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON???TIMI 38 trial: a pharmacogenetic analysis, The Lancet, vol.376, issue.9749, pp.376-1312, 2010.
DOI : 10.1016/S0140-6736(10)61273-1

W. J. Sandberg, The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis, Thromb Haemost, vol.102, issue.4, pp.704-714, 2009.

W. Ding, Serum sAPRIL: A potential tumor-associated biomarker to colorectal cancer, Clinical Biochemistry, vol.46, issue.15, pp.1590-1594, 2013.
DOI : 10.1016/j.clinbiochem.2013.06.008

C. Daridon, P. Youinou, J. O. Pers, A. Baff, and . Twe-pril, BAFF, APRIL, TWE-PRIL: Who's who?, Autoimmunity Reviews, vol.7, issue.4, pp.267-71, 2008.
DOI : 10.1016/j.autrev.2007.05.002

J. Zhao, The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.15, issue.6, pp.43-462, 2014.
DOI : 10.1111/j.1756-185X.2012.01814.x

T. Koyama, A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus, Rheumatology, vol.42, issue.8, pp.42-980, 2003.
DOI : 10.1093/rheumatology/keg270

A. Kawasaki, Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese, Rheumatology, vol.46, issue.5, pp.776-82, 2007.
DOI : 10.1093/rheumatology/kem019

Y. H. Lee, APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility, Rheumatology, vol.46, issue.8, pp.46-1274, 2007.
DOI : 10.1093/rheumatology/kem093

URL : https://academic.oup.com/rheumatology/article-pdf/46/8/1274/5050905/kem093.pdf

W. Osman, Association of Common Variants in TNFRSF13B, TNFSF13, and ANXA3 with Serum Levels of Non-Albumin Protein and Immunoglobulin Isotypes in Japanese, PLoS ONE, vol.7, issue.4, p.32683, 2012.
DOI : 10.1371/journal.pone.0032683.s007

M. Yang, Genome-wide scan identifies variant in TNFSF13 associated with serum IgM in a healthy Chinese male population A genome-wide linkage scan reveals CD53 as an important regulator of innate TNF-alpha levels, PLoS One Eur J Hum Genet, vol.7, issue.108, pp.18-953, 2010.

L. Madisen, DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA The protection and stabilization of whole blood at room temperature, Am J Med Genet Biopreserv Biobank, vol.27, issue.25, pp.12-332, 1987.

A. Halsall, The quality of DNA extracted from liquid or dried blood is not adversely affected by storage at 4 degrees C for up to 24 h DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality, Int J Epidemiol Biochem Genet, vol.37, pp.31-38, 1993.

P. Y. Lee, Agarose Gel Electrophoresis for the Separation of DNA Fragments, Journal of Visualized Experiments, issue.62, p.2012
DOI : 10.3791/3923

J. Bonnet, Chain and conformation stability of solid-state DNA: implications for room temperature storage, Nucleic Acids Research, vol.38, issue.5, pp.1531-1577, 2010.
DOI : 10.1093/nar/gkp1060

URL : https://hal.archives-ouvertes.fr/hal-00968097

X. Liu, Evaluation of DNA/RNAshells for Room Temperature Nucleic Acids Storage, Biopreservation and Biobanking, vol.13, issue.1, 2014.
DOI : 10.1089/bio.2014.0060